Science Explorer Interactive view Map
Company · Milan · Italy

Mediolanum Farmaceutici (Italy)

mediolanum-farma.it/en/index.htmlROR OpenAlex
Research works
56
▼ 53% vs 2013–17
Citations
1.2k
21.9 per fractional work
Top-10% rate
24.0%
record average 16.5%
Open access
12%
world 28%

Not ranked overall: Mediolanum Farmaceutici (Italy) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

    Which keywords describe research at Mediolanum Farmaceutici (Italy)?

    By fractional works in all years, weighted toward what it does more of than the world: Alzheimer's Disease, Antimicrobial Resistance, Pharmacology, Synthesis, Toxicology, Drug Development, Neurodegenerative Diseases and Acetylcholinesterase.

    ▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

    Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

    All 40 words, with their numbers
    1. Alzheimer's Disease6▲ 39×6 topics
    2. Antimicrobial Resistance5▲ 38×4 topics
    3. Pharmacology5▲ 29×5 topics
    4. Synthesis5▲ 16×9 topics
    5. Toxicology5▲ 41×3 topics
    6. Drug Development5▲ 58×3 topics
    7. Neurodegenerative Diseases4▲ 37×3 topics
    8. Acetylcholinesterase4▲ 261×1 topic
    9. Cholinesterase Inhibitors4▲ 261×1 topic
    10. Anticancer3▲ 31×4 topics
    11. Inflammation3▲ 2.6×9 topics
    12. Antibiotic Pharmacokinetics3▲ 132×1 topic
    13. Critically Ill Patients3▲ 132×1 topic
    14. Medicinal Chemistry3▲ 16×5 topics
    15. Biological Activity3▲ 46×4 topics
    16. Alkaloids3▲ 71×2 topics
    17. Anticancer Agents3▲ 20×7 topics
    18. Clinical Practice Guidelines3▲ 8.9×5 topics
    19. Oxidative Stress3▲ 2.7×10 topics
    20. Amaryllidaceae2▲ 151×1 topic
    21. Cell Signaling2▲ 13×5 topics
    22. Galanthamine2▲ 151×1 topic
    23. Neurodegeneration2▲ 12×5 topics
    24. Biological Evaluation2▲ 27×3 topics
    25. Heterocyclic Compounds2▲ 22×3 topics
    26. Chemotherapy2▲ 4.5×4 topics
    27. Angiogenesis2▲ 7.2×3 topics
    28. Synaptic Plasticity2▲ 9.8×2 topics
    29. Vaccination2▲ 39×2 topics
    30. Antimicrobial Activity2▲ 15×2 topics
    31. Molecular Docking2▲ 20×2 topics
    32. Neuroendocrine Control2▲ 41×2 topics
    33. Genetic Variants2▲ 13×2 topics
    34. Drug Target Identification1▲ 35×1 topic
    35. Neuroinflammation1▲ 8.8×3 topics
    36. Pharmacokinetics1▲ 9.3×2 topics
    37. Virtual Screening1▲ 35×1 topic
    38. Community-Acquired Pneumonia1▲ 59×1 topic
    39. Growth Hormone1▲ 28×2 topics
    40. Pneumococcal Conjugate Vaccine1▲ 59×1 topic

    Which research topics does Mediolanum Farmaceutici (Italy) publish most on?

    By volume: Cholinesterase and Neurodegenerative Diseases, Antibiotics Pharmacokinetics and Efficacy, Chemical synthesis and alkaloids and Computational Drug Discovery Methods.

    Cholinesterase and Neuro…4Cholinesterase and Neurodegenerative Diseases: 4 fractional worksAntibiotics Pharmacokinetics and Efficacy: 3 fractional worksChemical synthesis and alkaloids: 2 fractional worksComputational Drug Discovery Methods: 1 fractional worksPneumonia and Respiratory Infections: 1 fractional worksSynthesis and Biological Evaluation: 1 fractional worksProteoglycans and glycosaminoglycans research: 1 fractional worksCancer therapeutics and mechanisms: 1 fractional worksAntibiotic Resistance in Bacteria: 1 fractional worksSympathectomy and Hyperhidrosis Treatments: 1 fractional works
    PharmacologyOrganic ChemistryComputational Theory and MathematicsEpidemiology4 others

    Area is fractional works; colour is the subfield each topic belongs to.

    1. 1 Cholinesterase and Neurodegenerative Diseases Pharmacology 4 works
    2. 2 Antibiotics Pharmacokinetics and Efficacy Pharmacology 3 works
    3. 3 Chemical synthesis and alkaloids Organic Chemistry 2 works
    4. 4 Computational Drug Discovery Methods Computational Theory and Mathematics 1 works
    5. 5 Pneumonia and Respiratory Infections Epidemiology 1 works
    6. 6 Synthesis and Biological Evaluation Organic Chemistry 1 works
    7. 7 Proteoglycans and glycosaminoglycans research Cell Biology 1 works
    8. 8 Cancer therapeutics and mechanisms Molecular Biology 1 works
    9. 9 Antibiotic Resistance in Bacteria Molecular Medicine 1 works
    10. 10 Sympathectomy and Hyperhidrosis Treatments Physiology 1 works

    How open and international is its research?

    Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

    openly available12.5%not open87.5%

    World: 28% of research is openly available.

    with international co-authors26.1%domestic only73.9%

    World: 19% is written across borders.

    How has Mediolanum Farmaceutici (Italy)'s research output changed?

    Output in 2018–2022 was 53% lower than in 2013–2017.

    1990200020102020
    grewheldshrank

    The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

    Other research institutions in Milan

    All research institutions in Milan

    Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.